Symptom checker
Select audience type

Switch between content for healthcare professionals (PRO) and general audience (GEN).

ADD CONDITION

items per page

Mi-Acid Gas Relief

Last content change checked dailysee data sync status

This product has been discontinued

Active ingredient
Dimethicone 80 mg
Other brand names
Dosage form
Tablet, Chewable
Route
Oral
Prescription status
OTC (over the counter)
Pregnancy
See Pregnancy Use Section
Lactation
See Lactation Use Section
Marketed in the U.S.
Since 2011
Label revision date
February 3, 2014
Drug Information (PDF)
Prescribing information, PDF file
Active ingredient
Dimethicone 80 mg
Other brand names
Dosage form
Tablet, Chewable
Route
Oral
Prescription status
OTC (over the counter)
CSA schedule
Not a scheduled drug
Pregnancy
See Pregnancy Use Section
Lactation
See Lactation Use Section
Marketed in the U.S.
Since 2011
Label revision date
February 3, 2014
Manufacturer
Aidarex Pharmaceuticals LLC
Registration number
part332
NDC root
33261-224
Drug Information (PDF)
Prescribing information, PDF file
Packaging Info (2 NDCs)
Packaging & NDC Codes (2)

If you are a healthcare professional or from the pharmaceutical industry please visit this version.

If you are a consumer or patient please visit this version.

Drug Overview

Mi-Acid Gas Relief is a medication designed to help relieve gas pain, pressure, and bloating. It contains simethicone, an antiflatulent that works by breaking up gas bubbles in your stomach and intestines, making it easier for your body to eliminate them.

This product comes in the form of 30 chewable tablets, providing a convenient option for those experiencing discomfort from gas-related symptoms. If you're feeling bloated or under pressure from gas, Mi-Acid Gas Relief may offer the relief you need.

Uses

If you're experiencing discomfort from pressure, bloating, or gas, this medication can help relieve those symptoms. It works effectively to ease the feeling of fullness and the discomfort associated with gas buildup in your digestive system. You can feel more comfortable and at ease after using it, allowing you to go about your day without the distraction of these uncomfortable sensations.

Dosage and Administration

You can take this medication by chewing 2 to 4 tablets thoroughly after meals and at bedtime, depending on your needs. It's important to not exceed 6 tablets in a single day unless your doctor has specifically instructed you to do so. Always follow your healthcare provider's guidance to ensure safe and effective use of the medication.

What to Avoid

You can feel reassured that there are no specific contraindications, controlled substance classifications, or risks of abuse or misuse associated with this medication. Additionally, there are no concerns regarding dependence (a condition where the body becomes reliant on a substance).

Since there are no explicit "do not take" or "do not use" instructions, it suggests that this medication is generally safe for use as directed. However, always consult with your healthcare provider for personalized advice and to ensure it’s appropriate for your individual health needs.

Side Effects

It's important to keep this medication out of reach of children. If you suspect an overdose, seek medical help or contact a poison control center right away.

Be aware that while using this medication, you may experience some side effects. If you notice any unusual reactions, it's best to consult with your healthcare provider for guidance.

Warnings and Precautions

It's important to keep this medication out of reach of children to prevent accidental ingestion. If you suspect an overdose, seek medical help or contact a poison control center right away.

Always follow your doctor's instructions and let them know if you experience any unusual symptoms. If you have any concerns or questions about your treatment, don't hesitate to reach out to your healthcare provider for guidance.

Overdose

If you suspect an overdose, it’s crucial to seek medical help right away or contact a poison control center. Signs of an overdose can vary, but they may include unusual symptoms that are more severe than what you would typically experience with the medication.

Don’t wait to see if symptoms improve; getting prompt assistance can be vital. Always keep emergency contact information handy, and remember that acting quickly can make a significant difference in your health and safety.

Pregnancy Use

When considering the use of Mi-Acid Gas Relief (simethicone) during pregnancy, it's important to note that there is no specific information available about its safety, dosage adjustments, or any special precautions for pregnant individuals. This means that the effects of this medication on pregnancy have not been clearly established.

If you are pregnant or planning to become pregnant, it's always best to consult with your healthcare provider before taking any medication, including over-the-counter products like Mi-Acid Gas Relief. They can provide personalized advice based on your health needs and circumstances.

Lactation Use

If you are breastfeeding, you can feel reassured that there are no specific warnings or recommendations regarding the use of this product while nursing. Additionally, there are no statements indicating that this product is excreted in breast milk or that it poses any risk to your infant. This means you can use it without concern for affecting your milk production or your baby's health.

Pediatric Use

It's important to keep this medication out of reach of children. If a child accidentally takes too much, seek medical help or contact a poison control center right away.

For older children, the recommended dosage is to chew 2 to 4 tablets thoroughly after meals and at bedtime, but do not exceed 6 tablets in a day unless a doctor advises otherwise. Always follow these guidelines to ensure your child's safety and well-being.

Geriatric Use

While there is no specific information about how this medication should be used by older adults, it’s important to approach any new treatment with caution. Since older adults may have different health needs and may be taking multiple medications, it’s always a good idea to discuss any new prescriptions with your healthcare provider. They can help ensure that the medication is safe and appropriate for you or your loved one, considering any existing health conditions or medications.

If you are caring for an older adult, be attentive to any changes in their health or behavior after starting a new medication. Regular check-ins with a healthcare professional can help manage any potential risks and ensure the best outcomes.

Renal Impairment

If you have kidney problems, it's important to know that there are no specific guidelines or dosage adjustments mentioned for your condition in the available information. This means that the usual recommendations for monitoring or safety considerations related to renal impairment (kidney issues) are not provided.

It's always best to discuss your individual situation with your healthcare provider, who can offer personalized advice and ensure that any medications you take are safe and appropriate for your kidney health.

Hepatic Impairment

If you have liver problems, it's important to know that the drug insert does not provide specific information about dosage adjustments, special monitoring, or precautions for your condition. This means that there are no tailored guidelines for how this medication may affect you differently due to your liver health.

Always consult your healthcare provider for personalized advice and to discuss any concerns you may have regarding your liver function and how it relates to your treatment. They can help ensure that your medication is safe and effective for you.

Drug Interactions

It's important to have open conversations with your healthcare provider about any medications or tests you may be taking. In this case, there are no known drug interactions or laboratory test interactions associated with the medication. However, always ensure that your healthcare provider is aware of all the medications you are using, as this helps them provide the best care tailored to your needs.

By discussing your full medical history and any other treatments, you can help prevent potential issues and ensure your safety.

Storage and Handling

To ensure the safety and effectiveness of your product, always check that the inner seal is intact before use. If the seal is broken, do not use the product. For proper storage, keep it at room temperature, away from high humidity and excessive heat—specifically, temperatures above 40°C (104°F) should be avoided. Following these guidelines will help maintain the product's quality and safety for your use.

Additional Information

You should take this medication orally by chewing 2 to 4 tablets thoroughly as needed after meals and at bedtime. It's important not to exceed 6 tablets in a day unless your doctor advises otherwise. Always follow your healthcare provider's instructions for safe use.

FAQ

What is Mi-Acid Gas Relief used for?

Mi-Acid Gas Relief is used to relieve gas pain, pressure, and bloating.

What is the active ingredient in Mi-Acid Gas Relief?

The active ingredient is simethicone, which acts as an antiflatulent.

How should I take Mi-Acid Gas Relief?

You should chew 2 to 4 tablets thoroughly as needed after meals and at bedtime, but do not exceed 6 tablets per day unless directed by a physician.

Are there any warnings associated with Mi-Acid Gas Relief?

Yes, keep it out of reach of children, and in case of overdose, seek medical help or contact a poison control center immediately.

Is Mi-Acid Gas Relief safe to use during pregnancy?

There are no specific warnings or recommendations regarding the use of Mi-Acid Gas Relief during pregnancy.

Can nursing mothers use Mi-Acid Gas Relief?

There are no specific warnings or recommendations regarding the use of this product in nursing mothers.

What should I do if the inner seal of the package is broken?

Do not use the product if the inner seal is broken.

How should I store Mi-Acid Gas Relief?

Store it at room temperature, avoiding high humidity and excessive heat above 40°C (104°F).

Packaging Info

Below are the non-prescription pack sizes of Mi-Acid Gas Relief (simethicone). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Packaging configurations for Mi-Acid Gas Relief.
Details

Drug Information (PDF)

This file contains official product information for Mi-Acid Gas Relief, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)

Description

Mi-Acid Gas Relief is an antiflatulent formulation containing 80 mg of simethicone per chewable tablet. It is designed to relieve symptoms associated with gas pain, pressure, and bloating. The product is available in a dosage form of 30 chewable tablets, providing a convenient option for managing discomfort related to excess gas.

Uses and Indications

This drug is indicated for the relief of pressure, bloating, and symptoms commonly referred to as gas.

There are no teratogenic or nonteratogenic effects associated with this drug.

Dosage and Administration

Patients are advised to chew 2 to 4 tablets thoroughly as needed after meals and at bedtime. The total daily dosage should not exceed 6 tablets unless otherwise directed by a physician. It is important for healthcare professionals to monitor patient adherence to these guidelines to ensure safe and effective use of the medication.

Contraindications

There are no contraindications associated with the use of this product. It is not classified as a controlled substance, and there are no known risks of abuse, misuse, or dependence. Additionally, there are no specific instructions indicating that the product should not be taken or used under any circumstances.

Warnings and Precautions

It is imperative to keep this medication out of reach of children to prevent accidental ingestion and potential harm.

In the event of an overdose, immediate medical assistance should be sought. Healthcare professionals are advised to contact a poison control center without delay to ensure appropriate management and intervention.

Side Effects

Patients should be advised to keep the medication out of reach of children. In the event of an overdose, it is crucial to seek medical assistance or contact a poison control center immediately.

No specific adverse reactions have been reported in clinical trials or postmarketing experiences beyond the warnings provided. It is essential for healthcare providers to monitor patients for any unexpected effects and to report them as necessary.

Drug Interactions

No drug interactions or drug and laboratory test interactions have been identified in the available data. Therefore, no specific recommendations for dosage adjustments or monitoring are necessary at this time.

Packaging & NDC

Below are the non-prescription pack sizes of Mi-Acid Gas Relief (simethicone). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Packaging configurations for Mi-Acid Gas Relief.
Details

Pediatric Use

Pediatric patients should be advised to keep this medication out of reach of children. In the event of an overdose, immediate medical assistance or contact with a poison control center is essential.

For dosing, pediatric patients are directed to chew 2 to 4 tablets thoroughly as needed after meals and at bedtime. The maximum recommended dosage is 6 tablets per day, unless otherwise directed by a physician.

Geriatric Use

There is no specific information regarding the use of this medication in geriatric patients, including dosage adjustments, safety concerns, or special precautions. Healthcare providers should exercise caution when prescribing this medication to elderly patients, as individual responses may vary. Monitoring for potential adverse effects and therapeutic efficacy is recommended in this population.

Pregnancy

There is no specific information regarding the use of Mi-Acid Gas Relief (simethicone) during pregnancy. The drug insert does not provide safety concerns, dosage modifications, or special precautions for pregnant patients. Therefore, healthcare professionals should consider the lack of data when advising women of childbearing potential and weigh the potential benefits against any unknown risks when prescribing this medication during pregnancy.

Lactation

There are no specific warnings or recommendations regarding the use of this product in nursing mothers. Additionally, there are no statements concerning the potential for excretion in breast milk or any associated risks to breastfed infants.

Renal Impairment

Patients with renal impairment have not been specifically addressed in terms of dosage adjustments, special monitoring, or safety considerations. Therefore, healthcare professionals should exercise caution and consider individual patient factors when prescribing to patients with reduced kidney function, as the absence of specific guidance necessitates careful clinical judgment.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to the use of this medication. Consequently, there are no established dosage adjustments, special monitoring requirements, or precautions outlined for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the available information.

Overdosage

In the event of an overdose, it is imperative to seek medical assistance or contact a poison control center without delay. Prompt intervention is crucial to mitigate potential adverse effects associated with the overdose.

Healthcare professionals should be aware that the symptoms of overdose may vary depending on the substance involved. Therefore, a thorough assessment of the patient's condition is essential. Monitoring vital signs and conducting a comprehensive evaluation will aid in determining the appropriate course of action.

Management of an overdose may involve supportive care, including the stabilization of the patient's airway, breathing, and circulation. Specific antidotes or treatments may be indicated based on the substance involved and the severity of the symptoms. Continuous monitoring and reassessment are recommended to ensure the patient's safety and to address any complications that may arise during the management process.

In summary, immediate medical intervention is critical in cases of overdose, and healthcare professionals should be prepared to implement appropriate management strategies based on the clinical presentation and available resources.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data limits the understanding of potential risks associated with the compound in nonclinical settings.

Postmarketing Experience

Adverse drug events have been reported voluntarily and through surveillance programs. Healthcare professionals and patients are encouraged to report any adverse events to the designated contact number, (800) 616-2471. This information contributes to the ongoing monitoring of the drug's safety profile.

Patient Counseling

Advise patients to take the medication exactly as prescribed by their healthcare provider. It is important for patients to understand the dosage and frequency of administration to ensure optimal therapeutic outcomes.

Inform patients about the potential side effects associated with the medication. Common side effects may include nausea, dizziness, or fatigue. Patients should be encouraged to report any severe or persistent side effects to their healthcare provider promptly.

Instruct patients to avoid consuming alcohol while taking this medication, as it may exacerbate side effects and reduce the medication's effectiveness.

Counsel patients on the importance of adhering to follow-up appointments and laboratory tests as recommended by their healthcare provider. These appointments are crucial for monitoring the patient's response to the medication and adjusting treatment as necessary.

Educate patients about the signs and symptoms of serious adverse reactions that may require immediate medical attention, such as difficulty breathing, swelling of the face or throat, or severe skin reactions. Patients should be advised to seek emergency care if they experience any of these symptoms.

Encourage patients to maintain an open line of communication with their healthcare provider regarding any concerns or questions they may have about their treatment. This dialogue is essential for ensuring safe and effective use of the medication.

Storage and Handling

The product is supplied in packaging that ensures integrity and safety. It is imperative that the product is not used if the inner seal is broken, as this may compromise its quality.

For optimal storage, the product should be kept at room temperature. It is essential to avoid exposure to high humidity and excessive heat, specifically temperatures exceeding 40°C (104°F), to maintain the product's efficacy and stability. Proper handling and storage conditions are crucial to ensure the product remains safe for use.

Additional Clinical Information

The medication is administered orally, with the recommended directions for use being to chew 2 to 4 tablets thoroughly as needed after meals and at bedtime. Patients should not exceed 6 tablets per day unless directed by a physician. There is no additional information available regarding laboratory tests, abuse potential, patient counseling, or postmarketing experience.

Drug Information (PDF)

This file contains official product information for Mi-Acid Gas Relief, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)

Data Generation & Sources

This page was automatically generated and is maintained by the AllDrugs AI Data-Science Team. It was built from the FDA Structured Product Label (DailyMed) for Mi-Acid Gas Relief, retrieved by a validated AI data-extraction workflow.

All FDA-listed dosage forms and strengths are shown in the Packaging & NDC Codes section above. Regulatory status appears in the Summary Information panel above and was verified in the FDA National Drug Code directory and the NSDE NDC Directory daily file.

Note: an automated daemon monitors NSDE checksums; when the record for this NDC changes, the new file is pulled instantly and this page is refreshed.

No human clinician has reviewed this version.

Learn more in our Editorial Policy

Last AI update:

Primary FDA sources:

Orange Book data shown on this page are limited to Regulatory Status (Rx), Established Pharmacologic Class (EPC), and Mechanism of Action (MoA).

Regulatory data notice: Information on this page is reproduced verbatim from FDA public databases (NSDE, Orange Book, Purple Book, DailyMed SPL). NDA/ANDA drugs are FDA-approved, BLA biologics are FDA-licensed. Inclusion alone does not guarantee current market availability or imply FDA endorsement.

Medical disclaimer: This AI-generated content is provided for educational purposes only and does not constitute medical advice. Always consult a licensed healthcare professional for diagnosis or treatment decisions.